J. Safra Asset Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-196
Closed -$10.7K 639
2025
Q3
$10.7K Sell
196
-27
-12% -$1.35K ﹤0.01% 262
2025
Q2
$11.8K Buy
223
+21
+10% +$1.07K ﹤0.01% 283
2025
Q1
$8.74K Buy
202
+181
+862% +$9.17K ﹤0.01% 299
2024
Q4
$1.18K Buy
21
+2
+11% +$124 ﹤0.01% 309
2024
Q3
$1.25K Buy
+19
New +$1.07K ﹤0.01% 270

Other funds holding EXAS

J. Safra Asset Management's EXAS Position: Q4 2025 in Review

J. Safra Asset Management sold out of Exact Sciences (EXAS) in Q4 2025, closing a stake of 196 shares — an estimated $10.7K sold.

J. Safra Asset Management first reported a position in EXAS in Q3 2024 and held it in 5 quarters. The position peaked at $11.8K in Q2 2025. 711 funds tracked by Wall St. Rank hold EXAS as of Q4 2025.

  • J. Safra Asset Management reported no remaining Exact Sciences position as of Q4 2025 after selling out during the quarter.
  • J. Safra Asset Management sold 196 Exact Sciences shares in Q4 2025, an estimated $10.7K.
  • J. Safra Asset Management first reported a position in Exact Sciences in Q3 2024 and held it in 5 quarters.
  • J. Safra Asset Management's Exact Sciences position peaked at $11.8K in Q2 2025.
  • 711 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2025.

Based on J. Safra Asset Management's 13F filing for Q4 2025, filed 11 Feb 2026.